Grifols SA (GRFS)
7.985
-0.02
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
7.985
0.00 (0.00%)
After-Hours: 20:00
Grifols Enterprise Value : 14.00B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 14.00B |
| August 20, 2026 | 14.00B |
| August 19, 2026 | 14.06B |
| August 18, 2026 | 13.93B |
| August 17, 2026 | 13.94B |
| August 14, 2026 | 13.94B |
| August 13, 2026 | 13.98B |
| August 12, 2026 | 13.98B |
| August 11, 2026 | 14.00B |
| August 10, 2026 | 14.01B |
| August 07, 2026 | 13.98B |
| August 06, 2026 | 13.96B |
| August 05, 2026 | 13.98B |
| August 04, 2026 | 14.02B |
| August 03, 2026 | 13.96B |
| July 31, 2026 | 13.97B |
| July 30, 2026 | 14.05B |
| July 29, 2026 | 14.04B |
| July 28, 2026 | 14.00B |
| July 27, 2026 | 13.93B |
| July 24, 2026 | 13.89B |
| July 23, 2026 | 13.88B |
| July 22, 2026 | 13.97B |
| July 21, 2026 | 13.93B |
| July 20, 2026 | 13.90B |
| Date | Value |
|---|---|
| July 17, 2026 | 13.81B |
| July 16, 2026 | 13.83B |
| July 15, 2026 | 13.80B |
| July 14, 2026 | 13.75B |
| July 13, 2026 | 13.79B |
| July 10, 2026 | 13.81B |
| July 09, 2026 | 13.82B |
| July 08, 2026 | 13.82B |
| July 07, 2026 | 13.80B |
| July 06, 2026 | 13.79B |
| July 02, 2026 | 13.78B |
| July 01, 2026 | 13.76B |
| June 30, 2026 | 13.76B |
| June 29, 2026 | 14.98B |
| June 26, 2026 | 14.99B |
| June 25, 2026 | 14.99B |
| June 24, 2026 | 14.95B |
| June 23, 2026 | 14.94B |
| June 22, 2026 | 14.96B |
| June 18, 2026 | 15.00B |
| June 17, 2026 | 15.01B |
| June 16, 2026 | 15.04B |
| June 15, 2026 | 15.05B |
| June 12, 2026 | 15.06B |
| June 11, 2026 | 15.02B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Autolus Therapeutics Plc | 806.14M |
| argenx SE | 64.28B |
| Evaxion AS | 20.71M |
| Akari Therapeutics Plc | 6.680M |
| Pharma Mar SA | 1.378B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 212.78M |
| Revenue (Quarterly) | 2.179B |
| Total Expenses (Quarterly) | 2.000B |
| EPS Diluted (Quarterly) | 0.2631 |
| Gross Profit Margin (Quarterly) | 37.57% |
| Profit Margin (Quarterly) | 9.77% |
| Earnings Yield | 9.70% |
| Operating Earnings Yield | 25.86% |
| Normalized Earnings Yield | 9.704 |